MTD
METTLER TOLEDO INTERNATIONAL INC/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$1,625.73
+0.21%Year over year
Reported trailing growth
- Revenue
- +6.9%
- EBITDA
- +7.1%
- EBIT
- +7.0%
- EPS
- +12.4%
- Free cash flow
- +1.9%
- Operating cash flow
- +2.5%
Forward estimates
Based on analyst estimates
- Revenue
- +5.9%
- EBITDA
- +10.4%
- EPS
- +13.3%
Three-year CAGR
- Revenue
- +0.9%
- EBITDA
- +0.1%
- EBIT
- -0.2%
- Net income
- -0.1%
- EPS
- +2.8%
- Free cash flow
- +4.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026